STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
63 hedge funds and large institutions have $47M invested in Stemline Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $57K
Holders
63
Holding in Top 10
–
Calls
–
Puts
$57K
Top Buyers
| 1 | +$1.26M | |
| 2 | +$442K | |
| 3 | +$318K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$232K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$170K |
Top Sellers
| 1 | -$507K | |
| 2 | -$424K | |
| 3 | -$249K | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$240K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$141K |